$3.92
+0 (+0%)
At Close: Nov 13, 2025
ReShape Lifesciences® Announces Pricing of $3.0 Million Public Offering
12:30pm, Friday, 29'th Sep 2023
IRVINE, Calif., Sept. 29, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the pricing of i
ReShape Lifesciences® Announces Participation in the LD Micro Main Event XVI
08:31am, Friday, 22'nd Sep 2023
IRVINE, Calif., Sept. 22, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Paul F.
ReShape Lifesciences Inc. (RSLS) Q2 2023 Earnings Call Transcript
10:26pm, Monday, 07'th Aug 2023
ReShape Lifesciences Inc. (NASDAQ:RSLS ) Q2 2023 Earnings Conference Call August 7, 2023 5:00 PM ET Company Participants Michael Miller - Rx Communications, IR Paul Hickey - President and CEO Tom Stan
ReShape Lifesciences® to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide Corporate Update
08:30am, Thursday, 11'th May 2023
SAN CLEMENTE, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it w
ReShape Lifesciences Inc. (RSLS) Q4 2022 Earnings Call Transcript
01:12pm, Saturday, 29'th Apr 2023
ReShape Lifesciences Inc. (NASDAQ:RSLS ) Q4 2022 Earnings Conference Call April 25, 2023 4:30 PM ET Company Participants Michael Miller - Investor Relations Paul Hickey - President & Chief Executive O
SAN CLEMENTE, Calif., April 27, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences ™ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced it will
Penny Stocks To Buy? 4 To Watch Now After Big News This Week
12:52pm, Monday, 03'rd Apr 2023
Penny stocks to watch with news this week. Are they a buy now or should you avoid them entirely?
ReShape Lifesciences® To Delay Year Ended December 31, 2022 Earnings Release and Conference Call
09:50pm, Tuesday, 28'th Mar 2023
SAN CLEMENTE, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it
ReShape Lifesciences® to Announce Financial Results for the Year Ended December 31, 2022, and Provide Corporate Update
08:30am, Wednesday, 22'nd Mar 2023
Conference Call to be Held at 8:00 am ET on Wednesday, March 29, 2023 Conference Call to be Held at 8:00 am ET on Wednesday, March 29, 2023
ReShape Lifesciences® to Present at the Q2 Virtual Investor Summit
08:30am, Wednesday, 15'th Mar 2023
SAN CLEMENTE, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Pa
7 Stocks That Just Have No Hope Left
06:30am, Friday, 24'th Feb 2023
Let's face it – there are some stocks to sell that just have no hope left. Hope is a great thing.
Why Is ReShape Lifesciences (RSLS) Stock Down 63% Today?
09:23am, Monday, 06'th Feb 2023
ReShape Lifesciences (NASDAQ: RSLS ) stock is falling hard on Monday as the company's shares pull back from a rally on Friday. RSLS stock saw a massive gain on Friday that had it finishing out normal
5 Investors Betting Big on Reshape Lifesciences (RSLS) Stock
01:52pm, Friday, 03'rd Feb 2023
One of the biggest movers in today's session, Reshape Lifesciences (NASDAQ: RSLS ) is absolutely skyrocketing. At the time of writing, RSLS stock has surged an impressive 150% in today's session al
Why Is Reshape Lifesciences (RSLS) Stock Up 136% Today?
07:58am, Friday, 03'rd Feb 2023
Reshape Lifesciences (NASDAQ: RSLS ) stock is rocketing higher on Friday as a filing mixup shines a light on the company's shares. According to a filing with the U.S. Securities and Exchange Commissio
ReShape Lifesciences Inc. (RSLS) Q3 2022 Earnings Call Transcript
12:52pm, Monday, 14'th Nov 2022
ReShape Lifesciences Inc. (NASDAQ:RSLS ) Q3 2022 Earnings Conference Call November 14, 2022 8:00 AM ET Company Participants Paula Schwartz - Managing Director-Rx Communications Group Paul Hickey - Pre
Sign In
Buy RSLS